A detailed history of Proffitt & Goodson Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Proffitt & Goodson Inc holds 59 shares of LLY stock, worth $49,962. This represents 0.01% of its overall portfolio holdings.

Number of Shares
59
Holding current value
$49,962
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $42,767 - $53,633
59 New
59 $53,000
Q1 2021

May 03, 2021

SELL
$164.32 - $212.72 $3,286 - $4,254
-20 Closed
0 $0
Q4 2020

Jan 25, 2021

SELL
$130.46 - $172.63 $18,264 - $24,168
-140 Reduced 87.5%
20 $3,000
Q1 2019

Apr 18, 2019

BUY
$111.31 - $131.02 $2,226 - $2,620
20 Added 14.29%
160 $21,000
Q3 2018

Nov 09, 2018

BUY
$85.86 - $107.31 $12,020 - $15,023
140 New
140 $15,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Proffitt & Goodson Inc Portfolio

Follow Proffitt & Goodson Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proffitt & Goodson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Proffitt & Goodson Inc with notifications on news.